Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
CNCR
63
HOLDINGS
nan%
ALSO IN CANC
CANC
56
HOLDINGS
0%
ALSO IN CNCR
SECTOR DRIFT (CNCR minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CNCR |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
CNCR Overweight Relative to CANC
 |
SCHRODINGER, INC. | -0.3% |
|
ORIC PHARMACEUTICALS INC | -0.3% |
|
CULLINAN ONCOLOGY, INC. | -0.4% |
|
JANUX THERAPEUTICS, INC. | -0.4% |
|
TERNS PHARMACEUTICALS, INC. | -0.5% |
|
COMPASS THERAPEUTICS, INC. | -0.5% |
|
TYRA BIOSCIENCE, INC | -0.6% |
|
ARRIVENT BIOPHARMA, INC. | -0.6% |
 |
HUTCHISON CHINA MEDITECH LIMITED SPO | -0.6% |
|
ARVINAS, INC. | -0.6% |
CNCR Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -7.1% |
|
BRIDGEBIO PHARMA, INC. | -4.5% |
 |
NOVARTIS AG | -4.4% |
|
ELI LILLY & CO | -4.2% |
|
ASTRAZENECA PLC | -4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
|
BRISTOL-MYERS SQUIBB CO | -3.8% |
|
MERCK & CO. INC. | -3.8% |
 |
GENMAB A/S SPONSORED ADR | -3.7% |
|
NUVALENT, INC. CLASS A | -3.4% |